Frieder Kröner

Dr. Frieder Kröner works on the analytical development and characterization of new biological entities as a Group Head in Bioanalytics at Novartis, Switzerland. He is heading a team which develops analytical methods for potency and biological impurities. He started working as a postdoctoral researcher at Novartis in 2013, taking over increasing responsibilities as a functional lead for bioassay development in 2015 in the bioanalytics department, supporting mainly late stage clinical projects. Dr. Kröner holds a doctoral degree in bioengineering with a focus on protein analytics from the Karlsruhe Institute of Technology in Germany.